ישראל -
עברית -
Ministry of Health
rootcanal materials & accessories
דנקר דנטל שיווק בע"מ. - רופא - חומרים ואביזרים לטיפול שורש
ישראל -
עברית -
Ministry of Health
rootcanal materials & accessories
דנקר דנטל שיווק בע"מ. - רופא - חומרים ואביזרים לטיפול שורש
ישראל -
עברית -
Ministry of Health
אדויל ליקווי-ג'לס 200
gsk consumer healthcare, israel ltd - ibuprofen - קפסולות ממולאות נוזל - ibuprofen 200 mg - ibuprofen - ibuprofen - for the relief of pain associated with headache, toothache, backache, muscular and menstrual pains. antipyretic. antiinflammatory for rheumatic diseases.
ישראל -
עברית -
Ministry of Health
root canal posts and acces., temp. filling
חורי דנט בע"מ - רופא שיניים
ישראל -
עברית -
Ministry of Health
silicone implants& accessories -all models approved by the fda ,canadian health canada,australian tga and or carrying a valid ce
נובוגולד בע"מ - רופא - משתלי סיליקון ונילווים
ישראל -
עברית -
Ministry of Health
זיאגן תמיסה לשתיה
glaxo smith kline (israel) ltd - abacavir as sulfate - תמיסה (פומי) - abacavir as sulfate 20 mg/ml - abacavir - abacavir - ziagen is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infected adults and children.
ישראל -
עברית -
Ministry of Health
אפיביר תמיסה לשתיה
glaxo smith kline (israel) ltd - lamivudine - תמיסה (פומי) - lamivudine 10 mg/ml - lamivudine - lamivudine - epivir (lamivudine) is indicated for use in combination with retrovir (zidovudine) for the treatment of human immunodeficiency virus (hiv) infection when antiretroviral therapy is warranted based on clinical and/or immunological evidence of disease progression.
ישראל -
עברית -
Ministry of Health
זובירקס תרחיף
glaxo smith kline (israel) ltd - aciclovir - תרחיף - aciclovir 200 mg / 5 ml - aciclovir - aciclovir - zovirax oral presentations are indicated for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes, for the suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients, for the prophylaxis of herpes simplex infections in immune-compromised patients and for the treatment of herpes zoster (shingles) infections. studies have shown that early treatment of shingles with zovirax has a beneficial effect on pain and can reduce the incidence of post-herpetic neuralgia (zoster associated pain). zovirax oral presentations should be considered for the treatment of chickenpox in certain groups at increased risk of severe varicella or its complications. these groups are as follows: 1. non-pregnant patients over 13 years-of-age who are otherwise healthy. 2. children over 12 months of age with a chronic cutaneous or pulmonary condition, or receiving long-term salicylate therapy. 3. children receiving sho